This inventor holds 9 USPTO granted patents and 9 published patent applications and 2 EPO patents. Top assignee: Cubist Pharmaceuticals, Incorporated. Active years: 2014-2015.
Company Filing History:
Years Active: 2014-2015
Title: Innovations of Dylan C Alexander
Introduction
Dylan C Alexander is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactamase inhibitors. With a total of 9 patents to his name, his work has had a considerable impact on antibiotic efficacy.
Latest Patents
One of his latest patents involves the use of aryl substituted diazabicyclooctanes (DBO) compounds that inhibit β-lactamases of class A, class C, or class D. These compounds are designed to potentiate β-lactam antibiotics. Specifically, the disclosure provides DBO compounds that, when utilized in the Synergy MIC Assay with a β-lactam antibiotic at a fixed concentration, demonstrate an MIC of 8 µg/mL or less against one or more isogenic β-lactamase expressing bacterial strains.
Career Highlights
Dylan has worked with prominent companies in the pharmaceutical industry, including Cubist Pharmaceuticals, Incorporated and Merck Sharp & Dohme Corp. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Throughout his career, Dylan has collaborated with talented individuals such as Yu Gui Gu and Yong He. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Dylan C Alexander's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective antibiotic treatments.